--- title: "Real-Time HCP Targeting: How Fast Should Pharma Act on Clinical Intent Signals?" description: Learn how signal latency affects real-time HCP targeting and how pharma teams can measure the time from clinical intent to HCP ad delivery. image: https://blog.doceree.com/hubfs/Image%20(7).jpg --- [Now Live Daily Command is live Explore](https://doceree.com/daily-command/launch) [![Doceree](https://doceree.com/images/doceree-logo.svg)](https://doceree.com/) [Agencies](https://doceree.com/agencies) [Publishers](https://doceree.com/publishers) [EHR](https://doceree.com/ehr) [Hospital & health system](https://doceree.com/health-system) [Schedule a demo](https://doceree.com/contact#form) Solutions [Agencies](https://doceree.com/) [Publishers](https://doceree.com/publishers) [EHR](https://doceree.com/ehr) [Hospital & health system](https://doceree.com/health-system) Channels [![ABM](https://doceree.com/images/logos%20for%20cards/abm.svg)](https://doceree.com/channels/abm) [![Programmatic](https://doceree.com/images/runs/channels/programmatic.svg)](https://doceree.com/channels/programmatic) [![POC](https://doceree.com/images/runs/channels/poc.svg)](https://doceree.com/channels/ehr) [![DOOH](https://doceree.com/images/runs/channels/dooh-cis.png)](https://doceree.com/channels/dooh-powered-by-clinical-intent-signals) [![Email](https://doceree.com/images/runs/channels/email.svg)](https://doceree.com/channels/email) [![SMS](https://doceree.com/images/runs/channels/sms.svg)](https://doceree.com/channels/sms) [![RepTwin](https://doceree.com/images/logos%20for%20cards/reptwin.svg)](https://doceree.com/channels/reptwin) Solutions [![Marketplace](https://doceree.com/images/logos%20for%20cards/marketplace.svg)](https://doceree.com/marketplace) [![Co-pay.com](https://doceree.com/images/logos%20for%20cards/copay.com.svg)](https://doceree.com/channels/co-pay) [![NEXT](https://doceree.com/images/logos%20for%20cards/next.svg)](https://doceree.com/channels/next) Insights [Blogs](https://blog.doceree.com/) [Events](https://blog.doceree.com/events) [Media](https://info.doceree.com/media) [White paper](https://info.doceree.com/white-papers) [Case Studies](https://info.doceree.com/case-studies) [Ai Health 25](https://doceree.com/ai-health-25) [Health Decode](https://doceree.com/health-decode) About [Our Story](https://doceree.com/our-story) [Our Technology](https://doceree.com/technology) [Careers](https://doceree.com/careers) [Contact us](https://doceree.com/contact) [Exchange Login](https://exchange.doceree.com/login) [Schedule a demo](https://doceree.com/contact#form) [Available on Daily command](https://doceree.com/daily-command) ![Real-Time HCP Targeting with Clinical Intent Signals](https://blog.doceree.com/hubfs/Image%20(7).jpg) [Home](https://blog.doceree.com/) \> [HCP Marketing](https://blog.doceree.com/tag/hcp-marketing) Share [facebook-f icon](http://www.facebook.com/share.php?u=https://blog.doceree.com/clinical-intent-signals-hcp-targeting/) [linkedin-in icon](http://www.linkedin.com/shareArticle?mini=true&url=https://blog.doceree.com/clinical-intent-signals-hcp-targeting/) [twitter icon](https://twitter.com/intent/tweet?url=https://blog.doceree.com/clinical-intent-signals-hcp-targeting/) [pinterest-p icon](http://pinterest.com/pin/create/link/?url=https://blog.doceree.com/clinical-intent-signals-hcp-targeting/) [envelope icon](mailto:?body=https://blog.doceree.com/clinical-intent-signals-hcp-targeting/) # Real-Time HCP Targeting: How Fast Should Pharma Act on Clinical Intent Signals? September 24, 2026 Author: [Doceree](https://blog.doceree.com/author/doceree) 3 minute read Real-time HCP targeting is not just about receiving fresh data. It is about how quickly that data can change who a campaign reaches, what message is delivered and when the HCP sees it. An HCP's clinical context can change between a diagnosis, a treatment decision, a prescription, an access issue and a fill. If the campaign responds after that context has changed, the signal may still be accurate, but the message may no longer be as relevant. The challenge for pharma marketers is therefore not simply collecting more real-time data. It is using current clinical intent to make HCP targeting and media decisions before that context changes. **What Real-Time HCP Targeting Involves** A clinical signal must move through several stages before it becomes an ad impression: Clinical activity → signal detection → HCP identification → audience activation → ad delivery Each stage can cause delay. Doceree's [Clinical Intent Signals](https://www.prnewswire.com/news-releases/doceree-launches-clinical-intent-signals-the-industrys-first-real-time-clinical-intent-layer-for-omnichannel-healthcare-marketing-302795325.html) are designed to identify intent around the HCP's prescribing decision using signals from clinical and professional activity. Doceree's current technology positioning includes EHR activity, prescribing behavior, point-of-care context and other decision-moment signals. Detecting a clinical signal is only the first step. The signal still must be matched to the right HCP, activated within the campaign and delivered through the right channel. For pharma teams, the real measure is the time between the clinical event and the first relevant exposure. ## **Where Latency Enters HCP Targeting** **1. Signal detection** The first question is simple: **when did the relevant clinical activity happen?** A platform may process information quickly after receiving it, but that does not automatically tell marketers how recent the original activity was. This is why data freshness should be measured from the underlying event, not only from the latest platform update. **2. Verified HCP Identity** The clinical signal then needs to be connected to the right HCP. Doceree combines Clinical Intent Signals with verified provider identity to support NPI-level targeting. This connects the clinical context with the physician the campaign is intended to reach. Without accurate HCP identity, even a strong clinical signal has limited value for activation. **3. Signal-to-Activation** Once the HCP is identified, the signal needs to influence the campaign. The audience and targeting rules must update so the HCP becomes eligible for the relevant message. Delays at this stage can reduce the value of a signal before activation even begins. This is where clinical intent moves from insight to media action. **4. Activation-to-Exposure** Activation is complete only when the relevant message reaches the HCP. Delivery depends on the channel, available inventory and campaign settings. The timing can therefore differ across point of care, programmatic, social and other HCP media channels. For pharma marketers, the useful metric is therefore not just **signal processing time**. It is **signal-to-exposure time**: how long it takes to move from the clinical signal to the first relevant HCP exposure ## **How Fast Should Pharma Act on Different Clinical Intent Signals?** Not every clinical signal needs the same response time. Signals tied to prescribing, treatment changes or access may require faster activation, while research or educational activity can support longer follow-up. The right timing depends on the signal, message and clinical context. ## **How Clinical Intent Signals Guide HCP Channel Activation** Clinical Intent Signals can inform HCP targeting across channels, but the timing should match the role of each channel. Point of care can reach HCPs closer to the clinical workflow, while [Programmatic](https://doceree.com/channels/programmatic), Social and CTV can extend engagement beyond that moment. Doceree’s Intent Powered HCP Suite applies Clinical Intent Signals across these channels to support more timely HCP engagement. The goal is not to activate every channel at once. It is to reach the HCP through the right channel while the clinical signal is still relevant. ## **Measure Signal-to-Exposure Time in Real-Time HCP Targeting** Fresh clinical intent data loses value if HCP activation happens too late. By the time the message is delivered, the prescribing, treatment or access context may already have changed. Pharma teams should track: - **Event-to-signal time:** Time from clinical activity to signal availability. - **Signal-to-activation time:** Time taken for the signal to influence HCP targeting. - **Activation-to-exposure time:** Time from activation to the first relevant ad impression. - **On-time HCP reach:** Percentage of eligible HCPs reached within the defined response window. These metrics show whether real-time HCP targeting is responding quickly enough to the clinical context. Clinical Intent Signals create more value when they reduce the gap between **clinical activity, verified HCP identification and media activation**.  See how [Clinical Intent Signals](https://doceree.com/technology) can support faster, more relevant HCP targeting across channels.  ## **Frequently asked questions** | 1. What are Clinical Intent Signals in Doceree? | | --- | | Clinical Intent Signals capture clinical activity around an HCP’s prescribing decision and the patient’s path to therapy. Doceree uses signals from areas such as diagnosis, prescribing, therapy changes, access, affordability and fulfilment to identify when clinical intent is forming or changing. | | 2. Does RepTwin replace pharma field reps? | | Doceree connects Clinical Intent Signals with verified HCP identity to support NPI-level targeting. Once a relevant clinical signal is identified, it can inform campaign activation, so HCP engagement is based on current clinical context rather than a static audience alone. | | 3. How does Doceree activate Clinical Intent Signals across HCP channels? | | Doceree uses Clinical Intent Signals across point of care and its wider HCP media ecosystem. Its Intent Powered HCP Suite extends this approach across CTV, Social and Programmatic, allowing the same clinical context to inform HCP engagement across different channels and stages of the care journey. | [All posts](https://blog.doceree.com/all) ### Leave a Comment ![Doceree](https://doceree.com/images/doceree-logo.svg) Doceree is the connected infrastructure beneath healthcare commercialization, linking every clinical signal, decision, and channel to the outcomes that matter. [![HIPAA](https://doceree.com/images/compliance%20logos/hippa.png)](https://www.hhs.gov/hipaa/index.html) [![California Consumer Privacy Act (CCPA)](https://doceree.com/images/compliance%20logos/ccpa.png)](https://oag.ca.gov/privacy/ccpa) [![General Data Protection Regulation (GDPR)](https://doceree.com/images/compliance%20logos/gdpr.png)](https://gdpr.eu/) [![Trustworthy Accountability Group (TAG)](https://doceree.com/images/compliance%20logos/tag.png)](https://www.tagtoday.net/) [![IAB Transparency & Consent Framework](https://doceree.com/images/compliance%20logos/iab.png)](https://iabeurope.eu/transparency-consent-framework/) [![IAB Tech Lab](https://doceree.com/images/compliance%20logos/iab%20techlab.png)](https://iabtechlab.com/) [![Dun & Bradstreet Registered](https://doceree.com/images/compliance%20logos/dun.png)](https://profiles.dunsregistered.com/TPIN-BAS-004.aspx) ### Quick links - [Agencies](https://doceree.com/) - [Publishers](https://doceree.com/publishers) - [EHR](https://doceree.com/ehr) - [Hospital & Health System](https://doceree.com/health-system) - [Daily Command](https://doceree.com/daily-command) - [Our Story](https://doceree.com/our-story) - [Our Technology](https://doceree.com/technology) - [AI Health 25](https://doceree.com/ai-health-25) - [Health Decode](https://doceree.com/health-decode) - [co-pay.com](https://doceree.com/channels/co-pay) - [Marketplace](https://doceree.com/marketplace) - [Next](https://doceree.com/channels/next) ### Channels - [ABM](https://doceree.com/channels/abm) - [Programmatic](https://doceree.com/channels/programmatic) - [POC](https://doceree.com/channels/ehr) - [DOOH](https://doceree.com/channels/dooh-powered-by-clinical-intent-signals) - [Email](https://doceree.com/channels/email) - [SMS](https://doceree.com/channels/sms) - [RepTwin](https://doceree.com/channels/reptwin) ### Policies - [Privacy Policy](https://doceree.com/privacy-policy) - [Terms of Service - Advertiser](https://doceree.com/us-terms-of-service-advertiser) - [Program Policy Terms](https://doceree.com/us-program-policy-terms) - [Content Policy](https://doceree.com/us-content-policy) - [Media and Partner Resources](https://doceree.com/media-and-partner-resources) - [Patient Affordability Program Policy](https://doceree.com/us-patient-affordability-program-policy) - [Terms of Service - Marketplace](https://doceree.com/us-terms-of-service-marketplace) ### Address **US Headquarters** 150 John F Kennedy Pkwy, Suite 403, Short Hills, NJ 07078 **UK Office** MYO King's Cross, 50 York Way, London N1 9AB **India Office** Max Square, Floor 11, Plot No. C-3-C, Jaypee Wishtown, Noida, Sector 129, UP 201304 Follow us ```json { "@context" : "https://schema.org", "@type" : "BlogPosting", "author" : { "@type" : "Person", "name" : "Doceree", "url" : "https://blog.doceree.com/author/doceree" }, "dateModified" : "2026-09-24T10:30:44.325Z", "datePublished" : "2026-09-23T13:28:58.000Z", "headline" : "Real-Time HCP Targeting: How Fast Should Pharma Act on Clinical Intent Signals?", "image" : [ "https://blog.doceree.com/hubfs/Image%20(7).jpg" ], "mainEntityOfPage" : { "@id" : "https://blog.doceree.com/clinical-intent-signals-hcp-targeting/", "@type" : "WebPage" }, "publisher" : { "@type" : "Organization", "logo" : { "@type" : "ImageObject", "url" : "https://blog.doceree.com/hubfs/doceree_logo-1.png" }, "name" : "Doceree Inc" } } ``` ```json { "@context" : "https://schema.org", "@type" : "Blog", "description" : "Explore Doceree’s Blog for expert insights on healthcare marketing, programmatic ads, and HCP engagement. Stay ahead with actionable strategies and industry trends.", "name" : "Doceree Blog", "publisher" : { "@type" : "Organization", "address" : [ { "@type" : "PostalAddress", "addressCountry" : "US", "addressLocality" : "Short Hills", "addressRegion" : "NJ", "postalCode" : "07078", "streetAddress" : "150 John F Kennedy Pkwy, Suite 420" }, { "@type" : "PostalAddress", "addressCountry" : "UK", "addressLocality" : "London", "postalCode" : "W1U 6AG", "streetAddress" : "83 Baker Street, Spaces" }, { "@type" : "PostalAddress", "addressCountry" : "IN", "addressLocality" : "Noida", "addressRegion" : "Uttar Pradesh", "postalCode" : "201304", "streetAddress" : "Max Square, Floor 11, Plot No. C3-C, Jaypee Wishtown, Noida-Greater Noida Expressway, Sector 129" } ], "contactPoint" : [ { "@type" : "ContactPoint", "areaServed" : "US", "availableLanguage" : [ "English" ], "contactType" : "Office Contact", "telephone" : "+1 973-262-5856" }, { "@type" : "ContactPoint", "areaServed" : "UK", "availableLanguage" : [ "English" ], "contactType" : "Office Contact", "telephone" : "+44 7480 917683" }, { "@type" : "ContactPoint", "areaServed" : "India", "availableLanguage" : [ "English", "Hindi" ], "contactType" : "Office Contact", "telephone" : "+91 96850 96363" } ], "founder" : { "@type" : "Person", "name" : "Harshit Jain MD", "sameAs" : [ "https://www.linkedin.com/in/harshitjain/", "https://www.harshitjain.co/", "https://twitter.com/doctorhj", "https://www.facebook.com/drharshitjain" ] }, "foundingDate" : "2020", "logo" : "https://doceree.com/wp-content/uploads/2022/06/doceree-pharmaceutical-marketing-company.svg", "name" : "Doceree", "url" : "https://doceree.com/" }, "sameAs" : [ "https://www.facebook.com/doceree/", "https://linkedin.com/company/doceree", "https://twitter.com/doceree", "https://info.doceree.com/", "https://doceree.com/", "https://en.wikipedia.org/wiki/Doceree", "https://yourstory.com/companies/doceree", "https://www.crunchbase.com/organization/doceree", "https://theorg.com/org/doceree", "https://tracxn.com/d/companies/doceree/__S6DPb1DNqPS5n6DyxOXny8RbvRH1fL7ZK6LvKOmzk_M" ], "url" : "https://blog.doceree.com/" } ``` ```json { "@context" : "https://schema.org", "@id" : "https://blog.doceree.com/doceree-dialogue-e15-ai-in-healthcare-pharma-marketing", "@type" : "PodcastEpisode", "actor" : [ { "@type" : "Person", "jobTitle" : "Chief Growth Officer", "name" : "Ritesh Patel", "worksFor" : { "@type" : "Organization", "name" : "Doceree" } }, { "@type" : "Person", "jobTitle" : "Senior Manager of Insights & Analysis", "name" : "Dan Lynch", "worksFor" : { "@type" : "Organization", "name" : "M3MI" } } ], "associatedMedia" : { "@type" : "VideoObject", "contentUrl" : "https://www.youtube.com/watch?v=9kD08EMsQ-g", "description" : "Dan Lynch of M3MI explores how AI in healthcare, audience intelligence, and continuous optimization are reshaping pharma marketing strategies in an increasingly complex digital ecosystem.", "embedUrl" : "https://www.youtube.com/embed/9kD08EMsQ-g?si=44Uts4w8p8JALQgo", "name" : "Doceree Dialogue - Ep 15 | What Pharma Data Gets Right—and What It Still Misses", "publisher" : { "@type" : "Organization", "logo" : { "@type" : "ImageObject", "url" : "https://blog.doceree.com/hubfs/doceree-white-logo-new.svg" }, "name" : "Doceree" }, "thumbnailUrl" : "https://img.youtube.com/vi/9kD08EMsQ-g/maxresdefault.jpg", "uploadDate" : "2026-02-21T00:00:00+00:00" }, "dateModified" : "2026-09-24", "datePublished" : "2026-09-23", "description" : "In this episode of Doceree Dialogue, Dan Lynch, Senior Manager of Insights & Analysis at M3MI, joins Doceree to discuss how pharma marketing is shifting from data-driven to AI-driven decision-making, the role of personalization, and the future of omnichannel healthcare engagement.", "image" : { "@type" : "ImageObject", "url" : "https://blog.doceree.com/hubfs/doceree-dialogue-episode-15-ai-in-healthcare-pharma-data-dan-lynch-1.jpg" }, "name" : "Doceree Dialogue Episode 15 | From Dashboards to Decisions: Rethinking Pharma Marketing in an AI-First World", "partOfSeries" : { "@id" : "https://doceree.com/doceree-dialogue", "@type" : "PodcastSeries", "name" : "Doceree Dialogue" }, "url" : "https://blog.doceree.com/doceree-dialogue-e15-ai-in-healthcare-pharma-marketing" } ``` ```json { "@context" : "http://schema.org", "@type" : "Article", "author" : { "@type" : "Person", "name" : [ "Doceree" ] }, "datePublished" : "2026-09-23T13:28:58+0000", "description" : "Learn how signal latency affects real-time HCP targeting and how pharma teams can measure the time from clinical intent to HCP ad delivery.", "headline" : "Real-Time HCP Targeting: How Fast Should Pharma Act on Clinical Intent Signals?", "image" : "https://info.doceree.com/hubfs/Image%20%287%29.jpg", "publisher" : { "@type" : "Organization", "logo" : { "@type" : "ImageObject", "url" : "https://f.hubspotusercontent-eu1.net/hubfs/24898002/doceree_logo-1.png" }, "name" : "Doceree US" }, "url" : "https://blog.doceree.com/clinical-intent-signals-hcp-targeting/" } ```